中国血液净化

中国血液净化 ›› 2022, Vol. 21 ›› Issue (01): 42-47.doi: 10.3969/j.issn.1671-4091.2022.01.010

• 基础研究 • 上一篇    下一篇

沉默交配型信息调节2同系物-1 激活剂SRT1720 对重度失血性休克/复苏大鼠急性肾损伤的治疗作用及机制

郑寿浩1,丁国明1   

  1. 1浙江省台州市第一人民医院肾内科
  • 收稿日期:2021-05-06 修回日期:2021-10-20 出版日期:2022-01-12 发布日期:2022-01-04
  • 通讯作者: 丁国明 dingguoming1984@126.com E-mail:dingguoming1984@126.com
  • 基金资助:
    台州市科学技术局(2017A33798)

Protective effect and mechanism of SIRT1 activator SRT1720 on acute renal injury induced by severe hemorrhagic shock/resuscitation in rats

  1. 1Department of Nephrology, Taizhou First People's Hospital, Taizhou 318020, China
  • Received:2021-05-06 Revised:2021-10-20 Online:2022-01-12 Published:2022-01-04

PDF

106

摘要： 【摘要】目的探讨沉默交配型信息调节2 同系物-1(silent mating type information regulation 2 homolog 1，SIRT1)激活剂SRT1720 对重度失血性休克/复苏致大鼠急性肾损伤的治疗作用及机制。方法模型组、SIRT1 激活剂SRT1720 低、中、高剂量组(20、40、80mg/kg)建立重度失血性休克/复苏致大鼠急性肾损伤模型，建模成功后SIRT1激活剂SRT1720各剂量组给予相应药物，对照组、模型组给予等体积生理盐水；随后处死大鼠，测定肾/体比值、肌酐(SCr)、尿素氮(BUN)、肾脏SIRT1、信号转导转录激活剂-3
(signal transducers and activators of transcription factor 3，STAT3)mRNA 和蛋白水平、白细胞介素-2(IL-2)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平。结果与对照组比较，模型组肾/体比值、尿蛋白、SCr、BUN、IL-2、IL-6、TNF-α 升高(t 值分别为25.632、14.524、18.965、23.654、23.654、18.695、19.547，P 均＜0.001)；与模型组比较，SRT1720 各剂量组肾/体比值、尿蛋白、SCr、BUN、IL-2、IL-6、TNF- α 降低(t=21.526、19.654、23.654、25.148，32.654、19.654、21.548、25.965、24.967、28.741、30.365、31.654、23.654、18.475、26.548、29.512，30.248、24.659、24.965、22.698、26.985，P 均＜0.001)，且随着SRT1720 给药剂量的增加，肾/体比值、尿蛋白、SCr、BUN、IL-2、IL-6、TNF-α 逐渐降低，剂量-效应关系明显(t=38.632、19.625、25.847、27.489、26.954、29.547、32.685、34.489、32.362、24.548、29.654、28.415、35.957、32.548，P 均＜0.001)。与对照组比较，模型组肾SIRT1 mRNA 和蛋白水平降低(t=38.635、32.145，P 均＜0.001)，STAT3 mRNA 水平升高(t= 32.636、30.213, P 均＜0.001)；与模型组比较，SRT1720 各剂量组SIRT1 mRNA 和蛋白水平升高(t=18.965、23.147、28.476、30.216、23.654、28.471，P 均＜0.001)，STAT3 mRNA 和蛋白水平降低(t=22.654、25.489、29.548、33.265、41.326、29.635, P 均＜0.001)，且随着SRT1720 给药剂量增加，SIRT1 mRNA 和蛋白水平逐渐升高，STAT3 mRNA 和蛋白水平逐渐降低，剂量-效应关系明显(t=27.485、28.459、30.215、29.584、29.654、31.145、32.159、30.269，P 均＜0.001)。结论SIRT1 激活剂SRT1720 能减轻重度失血性休克/复苏致大鼠急性肾损伤；其机制与SIRT1激活剂SRT1720通过激活大鼠肾脏中SIRT1 表达，抑制STAT3 表达进而抑制炎性介质表达有关。

关键词: 沉默交配型信息调节2同系物-1 激活剂, SRT1720, 重度失血性休克/复苏, 急性肾损伤

Abstract: 【Abstract】Objective To explore the effect and mechanism of SRT1720, the activator of silent mating type information regulation 2 homolog-1 (SIRT1), on severe hemorrhagic shock/resuscitation-induced acute kidney injury. Methods Rats were divided into control group, model group, SIRT1 activator SRT1720 low (20 mg· kg-1) group, medium (40 mg/kg) group, and high dose (80 mg/kg) group. Rats were then subjected to acute severe hemorrhagic shock/resuscitation to induced acute kidney injury. After establishment of the disease model, equal volume of normal saline was given to the rats in control and model group, and various doses of SRT1720 were given to the rats in SRT1720 low, medium and high groups. Rats were then sacrificed, and their kidney/ body ratio, serum creatinine (SCr), urea nitrogen (BUN), SIRT1 in kidney, signal transducer and activator of transcription 3 (STAT3) mRNA and protein, interleukin-2 (IL-2), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured. Results In model group, kidney/body ratio, urinary protein, SCr, BUN, IL- 2, IL- 6, and TNF- α increased as compared with those in control group (t=25.632, 14.524,18.965, 23.654, 23.654, 18.695 and 19.547 respectively, P＜0.001). In SRT1720 low, medium and high
groups, kidney/body ratio, urinary protein, SCr, BUN, IL- 2, IL- 6, and TNF-α decreased as compared with those in model group (t=21.526, 19.654, 23.654, 25.148, 32.654, 19.654 and 21.548, respectively, in SRT1720 low group; 25.965, 24.967, 28.741, 30.365, 31.654, 23.654 and 18.475, respectively, in SRT1720 medium group; 26.548, 29.512, 30.248, 24.659, 24.965, 22.698 and 26.985, respectively, in SRT1720 high group; P＜0.001); besides, SRT1720 dose and the lowering of the 7 biomarkers apparently have a dosEresponse relationship (t=38.632, 19.625, 25.847, 27.489, 26.954, 29.547 and 32.685, respectively, compared with those between SRT1720 low and medium groups; 34.489, 32.362, 24.548, 29.654, 28.415, 35.957 and 32.548, respectively,
compared with those between SRT1720 medium and high groups; P＜0.001). In model group, renal SIRT1 mRNA and protein decreased (t=38.635 and 32.145; P＜0.001) and STAT3 mRNA and protein increased (t=32.636 and 30.213, P＜0.001) as compared with those in control group. In SRT1720 low, medium and high groups, renal SIRT1 mRNA and protein increased (t=18.965 and 23.147 in SRT1720 low group; 28.476 and 30.216 in SRT1720 medium group; 23.654 and 28.471 in SRT1720 high group; P＜0.001) and STAT3 mRNA and protein decreased (t=22.654 and 25.489 in SRT1720 low group; 29.548 and 33.265 in
SRT1720 medium group; 41.326 and 29.635 in SRT1720 high group; P＜0.001) as compared with those in model group; additionally, SRT1720 dose and the changes of the 4 biomarkers apparently have a dosEresponse relationship (t=27.485, 28.459, 30.215 and 29.584, respectively, compared with those between SRT1720 low and medium groups; 29.654, 31.145, 32.159 and 30.269, respectively, compared with those between SRT1720 medium and high groups, P＜0.001). Conclusion The SIRT1 activator SRT1720 can alleviate acute renal injury induced by severe hemorrhagic shock/resuscitation in rats. The mechanisms may be that
SRT1720 activates the expression of SIRT1 and inhibits the expression of STAT3 in kidney, through which the expressions of inflammatory mediators are inhibited.

Key words: SIRT1 activator, SRT1720, Severe hemorrhagic shock/resuscitation, Acute renal injury

中图分类号: